Zülch price

Awarding of the Zülch Prize 2016 in the historical town hall of Cologne to Stefan Pfister (3rd from left) and Michael D. Taylor (2nd from left)

The Klaus Joachim Zülch Prize is a German science prize that has been awarded annually since 1990 for outstanding performance in basic neurological research . The award is named after the German neuroscientist and former head of the Max Planck Institute for Brain Research , Klaus-Joachim Zülch (1910–1988). It is endowed with 50,000 euros (as of 2010), which are raised by the Gertrud Reemtsma Foundation . The award is made by the Max Planck Society .

While two scientists are honored in most years, four scientists were honored in 2012, three in 2018 and only one in 2015.

Award winners

• 2019: Development and testing of a drug for spinal muscular atrophy
  • Adrian Krainer , Cold Spring Harbor Laboratory
  • Richard Finkel , Nemours Children's Hospital, Orlando
• 2018: The immune system in neurological diseases
  • Jerome Posner , Cornell University
  • Josep Dalmau , University of Pennsylvania , University of Barcelona
  • Angela Vincent , Oxford University
• 2017: Sleep, Coma and Consciousness
  • Steven Laureys , University of Liège
  • Giulio Tononi , University of Wisconsin – Madison
• 2016: Cancer forms in the cerebellum
  • Stefan Pfister , German Cancer Research Center , Heidelberg University Hospital
  • Michael D. Taylor , Hospital for Sick Children in Toronto
• 2015: brain imaging
  • Winfried Denk , Max Planck Institute for Neurobiology
• 2014: Research into metabolic diseases
  • Jeffrey M. Friedman , Rockefeller University
  • Stephen O'Rahilly , Cambridge University
• 2013: Structure and function of the reward system in the brain
  • Wolfram Schultz , Cambridge University
  • Raymond J. Dolan , University College London
• 2012: Optogenetics
  • Ernst Bamberg , Max Planck Institute for Biophysics in Frankfurt
  • Karl Deisseroth , Stanford University , USA
  • Peter Hegemann , Humboldt University Berlin
  • Georg Nagel , University of Würzburg
• 2011
  • Thomas Gasser , University of Tübingen : Genetic factors in Parkinson's disease
  • Robert L. Nussbaum , University of San Francisco , California, USA: Identification of the role of alpha-synuclein in Parkinson's and investigation of Lowe's syndrome
• 2010
  • Alastair Compston , University of Cambridge , UK: Fundamentals of Treating Multiple Sclerosis
  • Hans Lassmann , University of Vienna , Austria: Mechanisms of neurodegeneration in multiple sclerosis
• 2009
  • Daniel R. Weinberger , National Institute of Mental Health , Bethesda , Maryland, USA: Neurobiology and Genetics of Schizophrenia
  • Florian Holsboer , Max Planck Institute for Psychiatry , Munich: Biological causes and therapy of depression
• 2008
  • Darell D. Bigner , Duke University , Durham , North Carolina, USA: Molecular biology and therapy of malignant brain tumors
  • David Neil Louis , Harvard Medical School , Boston , Massachusetts, USA: Molecular genetic analysis of human brain tumors
• 2007
  • Graeme M. Clark , University of Melbourne , Australia: Development of Multi -Channel Cochlear Implants
  • John P. Donoghue , Brown University , Providence , Rhode Island, USA: Development of implantable neuromotor prostheses
• 2006
  • David Julius , University of California, San Francisco , California, USA: Molecular mechanisms of pain and temperature sensation
  • Peter Jannetta , University of Pittsburgh , Pennsylvania, USA: Decompression therapy for trigeminal neuralgia
• 2005
  • Samuel F. Berkovic , University of Melbourne , Australia: Molecular Genetics of Epilepsy
  • Christian E. Elger , University of Bonn : Neurophysiology and therapy of experimental and clinical epilepsy
• 2004
  • Richard SJ Frackowiak , University College London , United Kingdom: Imaging measurement methods for studying the functional architecture of the human brain
  • Nikos K. Logothetis , Max Planck Institute for Biological Cybernetics , Tübingen: Mechanisms of functional magnetic resonance tomography (fMRI)
• 2003
  • Katsuhiko Mikoshiba , University of Tokyo , Japan: IP3 receptor / calcium signaling in the development and function of the nervous system
  • Fred H. Gage , Salk Institute , La Jolla , California, USA: Neural stem cells and neurogenesis of the adult brain
• 2002
  • Michael M. Merzenich , University of California, San Francisco , California, USA: Brain plasticity and rehabilitation of the central nervous system
  • Martin E. Schwab , University of Zurich , Switzerland: Regeneration of the nervous system after traumatic damage
• 2001
  • Gillian Patricia Bates , King's College London , United Kingdom: Molecular pathogenesis of Huntington's disease
  • Jean-Louis Mandel , Université Louis Pasteur , Strasbourg, France: Triplet repeats and loss of gene functions in neurodegenerative diseases
• 2000
  • Alim Louis Benabid , University of Grenoble , France: Intracerebral stimulation for the treatment of Parkinson's disease
  • George Alvin Ojemann , University of Washington , Seattle , Washington, USA: Cortical organization of language, memory and learning in humans
• 1999
  • Thomas J. Jentsch , University of Hamburg : Ion channel diseases in hereditary forms of myotonia and epilepsy
  • Hartmut Wekerle , Max Planck Institute for Neurobiology , Martinsried : Experimental autoimmune diseases of the nervous system and multiple sclerosis
• 1998
  • Konrad Sandhoff , University of Bonn : Disorders of the sphingolipid metabolism in neurodegenerative hereditary diseases
  • Wilhelm Stoffel , University of Cologne : Molecular pathogenesis of neurological diseases with myelin sheath disorders
• 1997
  • Stanley B. Prusiner , University of San Francisco , California, USA: Prion hypothesis of communicable cancellous encephalopathy
  • Charles Weissmann , University of Zurich , Switzerland: Molecular biology of prion diseases
• 1996
  • Konstantin-Alexander Hossmann , Max Planck Institute for Neurological Research , Cologne: Systemic pathophysiology of brain ischemia
  • Michael A. Moskowitz , Harvard Medical School , Boston , Massachusetts, USA: Molecular pathogenesis of brain ischemia
• 1995
  • Konrad Beyreuther , Heidelberg University : Pathogenesis of Alzheimer's Disease
  • Colin L. Masters , University of Melbourne , Australia: Molecular Pathology of Alzheimer's Disease
• 1994
  • Wolf-Dieter Heiss , Max Planck Institute for Neurological Research , Cologne: Positron emission tomography of neurological diseases
  • Wolf Singer , Max Planck Institute for Brain Research , Frankfurt: Organization and interaction of cortical brain functions
• 1993
  • David Ingvar , University of Lund , Sweden: Measurement of regional cerebral blood flow to localize human brain functions
  • Lindsay Symon , Institute of Neurology , London , United Kingdom: Experimental and clinical pathophysiology of cerebral ischemia
• 1992
  • Otto Creutzfeldt , Max Planck Institute for Biophysical Chemistry , Göttingen: Neurophysiology of cognitive functions of the brain
  • Bo K. Siesjö , Lund University , Sweden: Molecular mechanisms of hypoglycemic and ischemic brain damage
• 1991
  • Paul Kleihues , University of Zurich , Switzerland: Molecular Neuro-Oncology
  • Georg Kreutzberg , Max Planck Institute for Psychiatry , Munich: Interaction between glial and nerve cells
• 1990
  • Lars Olson , Karolinska Institute , Solna, Sweden: Transplantation of nerve tissue for the treatment of Parkinson's disease
  • Anders Björklund , University of Lund , Sweden: Experimental studies on the treatment of neurological diseases by transplanting nerve tissue

Web links

• Zülch Prize at mpg.de; accessed on August 31, 2016

1. ↑ Award for therapy for muscle weakness. In: mpg.de. Max Planck Society , September 9, 2019, accessed on September 10, 2019 .